BiomX Inc. Sets 2024 Virtual Annual Meeting for July 9
Ticker: PHGE · Form: DEF 14A · Filed: Jun 17, 2024 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | DEF 14A |
| Filed Date | Jun 17, 2024 |
| Risk Level | low |
| Pages | 13 |
| Reading Time | 15 min |
| Key Dollar Amounts | $0.0001, $5.00, $50,000,000, $0.2311, $231.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-meeting, proxy-statement, corporate-governance
Related Tickers: BIIX
TL;DR
BiomX virtual shareholder meeting July 9th - vote your shares!
AI Summary
BiomX Inc. is holding its 2024 Annual Meeting of Stockholders online on July 9, 2024, at 8:00 a.m. Eastern Time. The proxy statement, dated June 17, 2024, outlines the details for this virtual meeting, allowing stockholders to participate remotely. No filing fee was required for this statement.
Why It Matters
This filing informs shareholders about the upcoming annual meeting, a key event for corporate governance where voting on important company matters takes place.
Risk Assessment
Risk Level: low — This is a standard proxy statement for an annual shareholder meeting, not indicating any immediate financial or operational risks.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- June 17, 2024 (date) — Proxy Statement Date
- July 9, 2024 (date) — Annual Meeting Date
- 8:00 a.m. Eastern Time (time) — Annual Meeting Time
FAQ
When is the 2024 Annual Meeting of Stockholders for BiomX Inc.?
The 2024 Annual Meeting of Stockholders for BiomX Inc. will be held on July 9, 2024.
What time is the annual meeting?
The meeting will begin at 8:00 a.m. Eastern Time.
How will the annual meeting be conducted?
This year's Annual Meeting will be held entirely online.
What is the date of the proxy statement?
The proxy statement is dated June 17, 2024.
Was there a filing fee for this proxy statement?
No fee was required for the filing of this proxy statement.
Filing Stats: 3,777 words · 15 min read · ~13 pages · Grade level 17.2 · Accepted 2024-06-17 11:26:31
Key Financial Figures
- $0.0001 — Convertible Preferred Stock, par value $0.0001 per share, and the exercise of certain
- $5.00 — of Common Stock at an exercise price of $5.00 per share, in each case subject to and
- $50,000,000 — ect with cash proceeds of not less than $50,000,000. •    �
- $0.2311 — of Common Stock at an exercise price of $0.2311 per share, for a combined purchase pric
- $231.10 — share, for a combined purchase price of $231.10 per share of Series X Preferred
- $50,000,000 b — roceeds to the Company of approximately $50,000,000 before deducting placement agent fees and
Filing Documents
- ea0207921-01.htm (DEF 14A) — 8940KB
- tbiomx_logo.jpg (GRAPHIC) — 32KB
- tbiomx_logo1.jpg (GRAPHIC) — 32KB
- tbarchart_001.jpg (GRAPHIC) — 418KB
- tbarchart_002.jpg (GRAPHIC) — 433KB
- ttable_001.jpg (GRAPHIC) — 369KB
- ttable_002.jpg (GRAPHIC) — 470KB
- ttable_003.jpg (GRAPHIC) — 256KB
- ttable_004.jpg (GRAPHIC) — 135KB
- ttable_005.jpg (GRAPHIC) — 416KB
- ttable_006.jpg (GRAPHIC) — 795KB
- ttable_007.jpg (GRAPHIC) — 744KB
- ttable_008.jpg (GRAPHIC) — 748KB
- ttable_009.jpg (GRAPHIC) — 292KB
- ttable_010.jpg (GRAPHIC) — 404KB
- ttable_011.jpg (GRAPHIC) — 480KB
- ttable_012.jpg (GRAPHIC) — 293KB
- ttable_015.jpg (GRAPHIC) — 135KB
- ttable_016.jpg (GRAPHIC) — 387KB
- ttable_013.jpg (GRAPHIC) — 995KB
- ttable_014.jpg (GRAPHIC) — 1033KB
- tadaptive_logo.jpg (GRAPHIC) — 105KB
- tproxy_001.jpg (GRAPHIC) — 1345KB
- tproxy_002.jpg (GRAPHIC) — 893KB
- 0001213900-24-053210.txt ( ) — 24381KB
RISK FACTORS
RISK FACTORS   98 BIOMX’S BUSINESS   99 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   100 DESCRIPTION OF BIOMX’S SECURITIES   107 WHERE YOU CAN FIND ADDITIONAL INFORMATION   110 HOUSEHOLDING   110 STOCKHOLDER PROPOSALS   111 OTHER MATTERS   111 INFORMATION INCORPORATED BY REFERENCE   112
FINANCIAL STATEMENTS OF BIOMX
FINANCIAL STATEMENTS OF BIOMX   F-1
FINANCIAL STATEMENTS OF APT
FINANCIAL STATEMENTS OF APT   F-26 ANNEX A — PROPOSED AMENDMENT TO CERTIFICATE OF INCORPORATION (S HARE INCR EASE AMENDMENT)   A-1 ANNEX B — PROPOSED AMENDMENT TO CERTIFICATE OF INCORPORATION (REVERSE STOCK SPLIT AMENDMENT)   B-1 ANNEX C — A&R PLAN   C-1 ANNEX D — OPINION OF H.C. WAINWRIGHT & CO., LLC   D-1 ANNEX E — AGREEMENT AND PLAN OF MERGER   E-1 ANNEX F — SECURITIES PURCHASE AGREEMENT   F-1 ANNEX G — SERIES X PREFERRED STOCK CERTIFICATE OF DESIGNATION   G-1 ANNEX H — FORM OF MERGER WARRANT   H-1 ANNEX I — FORM OF PRIVATE PLACEMENT WARRANT   I-1 ANNEX J — FORM OF PLACEMENT AGENT WARRANT   J-1 ANNEX K — FORM OF REGISTRATION RIGHTS AGREEMENT   K-1 ANNEX L — PRIVATE PLACEMENT INVESTORS   L-1 ANNEX M — PROXY CARD   M-1 ii Table of Contents SUMMARY TERM SHEET This summary term sheet, together with the sections entitled “ The Merger Agreement ” and “ The Private Placement ,” summarizes certain information contained in this proxy statement, but may not contain all of the information that is important to you. You should read carefully this entire proxy statement, including the attached Annexes, for a more complete understanding of the matters to be considered at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”). •          On March   6, 2024, BiomX entered into the an Agreement and Plan of Merger (the “Merger Agreement”) by and among BiomX, BTX Merger Sub I, I